Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
33.63
-0.14 (-0.41%)
At close: Aug 1, 2025, 4:00 PM
33.00
-0.63 (-1.87%)
After-hours: Aug 1, 2025, 5:13 PM EDT

Bright Minds Biosciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2020
229562085-
Upgrade
Market Cap Growth
5140.40%-18.98%-70.74%-75.79%--
Upgrade
Enterprise Value
189001467-
Upgrade
Last Close Price
33.631.171.606.1535.71-
Upgrade
PB Ratio
5.921.191.232.675.51-
Upgrade
P/TBV Ratio
5.921.191.232.675.52-
Upgrade
Debt / Equity Ratio
0.000.020.010.01--
Upgrade
Quick Ratio
87.6410.9224.168.0031.125.30
Upgrade
Current Ratio
88.2711.3224.268.1131.385.82
Upgrade
Return on Equity (ROE)
-11.21%-46.18%-86.02%-99.95%-85.94%-124.04%
Upgrade
Return on Assets (ROA)
-10.57%-25.19%-47.45%-57.32%-51.52%-61.70%
Upgrade
Return on Capital (ROIC)
-10.80%-26.53%-51.86%-61.21%-53.54%-76.64%
Upgrade
Earnings Yield
-1.04%-42.70%-90.90%-53.20%-8.09%-
Upgrade
Buyback Yield / Dilution
-39.99%-15.87%-50.58%-37.64%-148.42%-74.24%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q